Evidence map›Paper›PMID 29864380›Full record

ArticleAmerican journal of respiratory and critical care medicine2018

A Disintegrin and Metalloproteinase Domain-9: A Novel Proteinase Culprit with Multifarious Contributions to Chronic Obstructive Pulmonary Disease.

Xiaoyun Wang, Francesca Polverino, Joselyn Rojas-Quintero, Duo Zhang, José Sánchez, Ilyas Yambayev, Eva Lindqvist, Robert Virtala, Ratko Djukanovic, Donna E Davies and 8 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 37 citations in OpenAlex.

  1. Matrix Metalloproteinase-8 Deficiency Alters the Balance Between Viral Clearance and Immunopathology in H1N1 Infection.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Extracellular vesicle-encapsulated CC16 as novel nanotherapeutics for treatment of acute lung injury.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  13. Article
  14. Article
  15. IL-17A Promotes Epithelial ADAM9 Expression in Cigarette Smoke-Related COPD.International journal of chronic obstructive pulmonary disease · 2022
    Article
  16. Review
  17. Article
  18. Review
  19. ADAM15 expression is increased in lung CD8Respiratory research · 2020
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 4 countries.

Xiaoyun WangDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-9900-740X
Francesca PolverinoDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-9686-5698
Joselyn Rojas-QuinteroDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-4994-075X
Duo ZhangPulmonary Center, Boston University School of Medicine, Boston, Massachusetts.
José SánchezQuantitative Biology, Discovery Sciences.
Ilyas YambayevDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Eva LindqvistStudy Enterprise, Early Clinical Development at Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden.
Robert VirtalaEpithelium, Respiratory, Inflammation and Autoimmunity at Innovative Medicines and Early Development Biotech Unit, AstraZeneca Research & Development, Gothenburg, Sweden.
Ratko DjukanovicNational Institute for Health Research Southampton, Respiratory Biomedical Research Centre and Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Donna E DaviesNational Institute for Health Research Southampton, Respiratory Biomedical Research Centre and Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Susan WilsonHistochemistry Research Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Rory O'DonnellSt. James's Hospital, Dublin, Ireland; and.
Danen CunoosamyEpithelium, Respiratory, Inflammation and Autoimmunity at Innovative Medicines and Early Development Biotech Unit, AstraZeneca Research & Development, Gothenburg, Sweden.
Petra HazonEpithelium, Respiratory, Inflammation and Autoimmunity at Innovative Medicines and Early Development Biotech Unit, AstraZeneca Research & Development, Gothenburg, Sweden.
Andrew HighamMedicines Evaluation Unit, University of Manchester, Manchester University National Health Service Foundation Trust, Manchester, United Kingdom.
Dave SinghMedicines Evaluation Unit, University of Manchester, Manchester University National Health Service Foundation Trust, Manchester, United Kingdom.
Henric OlssonEpithelium, Respiratory, Inflammation and Autoimmunity at Innovative Medicines and Early Development Biotech Unit, AstraZeneca Research & Development, Gothenburg, Sweden.
Caroline A OwenDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-4377-3591
Brigham and Women's Hospital · USNational Health Service · GBNational Institute for Health Research · GBBoston University · USQuantitative BioSciences · US

Funding

Respiratory Computational Discovery CoreP01HL114501 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHOI, MARY E · 2013 to 2025
$24.9M
Systems Biology, Bioinformatics, and BiostatisticsP01HL105339 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2011 to 2015
$12.2M
Targeting MMP9 to Improve Outcomes in Serious Influenza InfectionsR01AI111475 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HARROD, KEVIN S, LEVY, BRUCE D · 2014 to 2018
$4.3M
Novel Roles for MMP-8 in Acute Lung InjuryR01HL063137 · NHLBI · UNIVERSITY OF UTAH · PI OWEN, CAROLINE A · 1999 to 2008
$2.6M
Novel Roles for ADAM15 in Acute Lung InjuryR01HL086814 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI OWEN, CAROLINE A · 2007 to 2010
$1.6M
Novel Anti-inflammatory Activities For ADAM8 In Pulmonary EmphysemaR21HL111835 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI OWEN, CAROLINE A · 2012 to 2013
$456k
NHLBI NIH HHS P01 HL105339NHLBI NIH HHS P01 HL114501NHLBI NIH HHS R01 HL063137NHLBI NIH HHS R01 HL086814NHLBI NIH HHS R21 HL111835NIAID NIH HHS R01 AI111475
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

emphysemagrowth factor receptorinflammationmucus metaplasiasmall-airway fibrosis

Identifiers

PMID29864380
PMCPMC6298633
OpenAlexW2805718585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.